[LGND] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
01-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -183.19%
YoY- -124.32%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 69,990 27,003 59,590 50,464 38,185 21,192 22,998 20.36%
PBT 3,370 -8,175 -56,789 30,665 7,230 5,826 7,012 -11.48%
Tax -2,391 -810 -14,307 37,675 10,355 -515 279 -
NP 5,761 -7,365 -42,482 -7,010 -3,125 6,341 7,055 -3.31%
Tax Rate 70.95% - - -122.86% -143.22% 8.84% -3.98% -
Total Cost 64,229 34,368 102,072 57,474 41,310 14,851 15,943 26.11%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 8.23 -27.27 -71.29 -13.89 -8.18 29.92 30.68 -19.67%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.36 -0.43 -2.02 -0.34 -0.15 0.32 0.35 0.47%
EPS Diluted 0.35 -0.43 -2.02 -0.33 -0.15 0.29 0.34 0.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.